Toronto-based Vida Cannabis (Canada) Ltd. is in preparation for large-scale, licensed production of pharmaceutical-grade marijuana. The company is organizing a growing, processing and shipping facility in Nova Scotia and has applied to Health Canada for licensed producer status under the Controlled Drugs and Substances Act's Marihuana for Medical Purposes Regulations (MMPR).

Vida's emphasis is on quality control, economies of scale and education. Product sales will be to medical-use clients properly registered under the MMPR.

Our management and staff look forward to assisting Canadians deal with medical conditions for which marijuana may be indicated. To that end, we will be active in patient education and in raising health care practitioner awareness of the technical literature relating to the medical effectiveness of cannabis and its active elements.

The efficiencies of large-scale production should allow us to operate profitably while providing customers with quality-assured products at affordable prices. Vida's medical marijuana operations will be located in Stellarton, Nova Scotia, in a highly secure, dedicated 315,000-square-foot indoor production facility. Initial production is expected to use approximately 10% of that space, leaving the potential for rapid increases in production rates as needed.

The greater Stellarton area of more than 10,000 people offers modern transportation and communication infrastructure, ample electrical and water supplies, an abundance of natural cooling and an industrious labour force. The local community has demonstrated strong support for our business and our service goals.

Vida Cannabis (Canada) Ltd. is a wholly owned subsidiary of Vida Cannabis Corp., a Delaware corporation. Our guiding principle is to satisfy all the standards of a responsible medical marijuana company.